The effect of changes in medicare reimbursement on the practice of office and hospital-based endoscopic surgery for bladder cancer

Cancer

Volumn 116, Issue 5, 2010, Pages 1264-1271

  Hemani, Micah L ^a   Makarov, Danil V ^b,c   Huang, William C ^a   Taneja, Samir S ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Bladder cancer; Cost analysis; Outpatient surgery; Physician incentives

Indexed keywords

ARTICLE; BLADDER CANCER; BLADDER SURGERY; CANCER DIAGNOSIS; CHI SQUARE TEST; CONTROLLED STUDY; CYSTOSCOPY; ENDOSCOPIC SURGERY; FACULTY PRACTICE; HEALTH CARE COST; HOSPITAL; HUMAN; HUMAN TISSUE; INTERVENTION STUDY; LOGISTIC REGRESSION ANALYSIS; MEDICARE; PRIORITY JOURNAL; REIMBURSEMENT; RISK;

AMBULATORY SURGICAL PROCEDURES; BIOPSY; ENDOSCOPY; HOSPITALIZATION; HUMANS; MEDICARE; PHYSICIAN'S PRACTICE PATTERNS; REIMBURSEMENT MECHANISMS; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 77149132153     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24875     Document Type: Article

References (16)

1. Botteman MF, Pashos CL, Redaelli A, et al. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics. 2003;21:1315-1330.
2. Avritscher EB, Cooksley CD, Grossman HB, et al. Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology. 2006;68:549-553.
3. Noyes K, Singer EA, Messing EM. Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors. Curr Opin Urol. 2008;18:533-539.
4. Donat SM, North A, Dalbagni G, et al. Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5cm. J Urol. 2004;171:636-639.
5. Centers for Medicare and Medicaid Services. Health Care Consumer Initiatives. Washington, DC: US Department of Health and Human Services, Centers for Medicare and Medicaid Services. Available at: http://www.cms.hhs.gov/ HealthCareConInit/ Accessed on December 31, 2009.
6. Angrisano C, Farrell D, Kocher B, et al. Accounting for the Cost of Health Care in the United States. Washington, DC: McKinsey Global Institute; 2007.
7. Pham H, Ginsburg P. Unhealthy trends: the future of physician services. Health Aff (Millwood). 2007;26:1586-1598.
8. Casalino L, Devers K, Brewster L. Focused factories? Physician-owned specialty facilities. Health Aff (Millwood). 2003;22:56-67.
9. Hillman AL. Managing the physician: rules versus incentives. Health Aff (Millwood). 1991;10:138-146.
10. Congressional Budget Office. Economic Projections. Washington, DC: Congressional Budget Office; 2009. Available at: http://www.cbo.gov/budget/ econproj.shtml Accessed on December 31, 2009.
11. Herr H, Donat S, Reuter V. Management of low grade papillary bladder tumors. J Urol. 2007;178:1201-1205.
12. Herr HW. Outpatient flexible cystoscopy and fulguration of recurrent superficial bladder cancer.J Urol. 1990;144:1365-1366.
13. Wedderburn AW, Ratan P, Birch BR. A prospective trial of flexible cystodiathermy for recurrent transitional cell carcinoma of the bladder. J Urol. 1999;161:812-814.
14. Muraishi O, Mitsu S, Suzuki K, et al. A technique for resection of small bladder tumors using a flexible cystoscope on an outpatient basis: bladder tumor resection with newly designed hot cup forceps. J Urol. 2001;166: 1817-1819.
15. Schrag D, Hseih LJ, Rabbani F, et al. Adherence to surveillance among patients with superficial bladder cancer. J Natl Cancer Inst. 2003;95:588-597.
16. Hollenbeck BK, Ye Z, Dunn RL, et al. Provider treatment intensity and outcomes for patients with early stage bladder cancer. J Natl Cancer Inst. 2009;101:571-580.